24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate
Clinical trial NCT01590459 · COMPLETED
Trial details
- NCT number
- NCT01590459
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-07-01
- Enrollment
- 359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.